BiondVax Pharmaceuticals Ltd (BVXV)

[TechKim]

I thought I saw the volume building. Of course profit takers were squeezing out some protective positions in my opinion.

We did get a 30% dilution in shares from December 31, 2016 to April 28, 2017. A dilution of 40,618,432 shares, a jump from 135,097,367 to 175,715,799. So I would assume activity would be active in profit taking as an ongoing concern looms without the added shares for financing. 33,760,832 that are presently restricted until the end of June 2017 will be allowed to be sold. So I would expect even more activity. The placement shares fees I am uncertain they are paid in shares or cash for the moment.

I am just looking for the escalation cause in volume. I do know if everyone heads for the exit all at once it going to be a hard sell for individuals.

We must remember clinical trials in the U.S. can average 10 years. That takes money, an in the course of financing many a young companies appear to get their shares diluted.

Just tossing out a small opinion.